Adult central core disease. Clinical, histologic and genetic aspects: Case report and review of the literature

Clinical Neuropathology

Volumn 25, Issue 4, 2006, Pages 180-184

  Talwalkar, S S ^a   Parker, J R ^a   Heffner, R R ^b   Parker, J C ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Central core disease; Malignant hyperthermia; Ryanodine receptor; Type I myofibers

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMLODIPINE BESYLATE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME C OXIDASE; MELOXICAM; OXIDOREDUCTASE; SUCCINATE DEHYDROGENASE;

ADULT; ANAMNESIS; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CENTRONUCLEAR MYOPATHY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONGENITAL DISORDER; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GENETIC ANALYSIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRION; MORPHOLOGY; MUSCLE BIOPSY; MUSCLE CELL; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM;

ADENOSINE TRIPHOSPHATASES; AGE OF ONSET; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MALE; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOPATHY, CENTRAL CORE; NAD; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SUCCINATE DEHYDROGENASE;

EID: 33745907529     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Armstrong RM, Koenigsberger R, Mellinger J, Lovelace RE. Central core disease with congenital hip dislocation: study of two families. Neurology. 1971; 21: 369-376.
2. Byrne E, Blumbergs PC, Hallpike JF. Central core disease: study of a family with five affected generations. J Neurol Sci. 1982; 55: 77-83.
3. Engel WK, Foster JB, Hughes BP, Huxley HE, Mahler R. Central core disease: an investigation of a rare muscle cell abnormality. Brain. 1961; 84: 167-185.
4. Greenfield JG, Cornman T, Shy GM. The prognostic value of the muscle biopsy in the floppy infant. Brain. 1958; 81: 461-484.
5. Hayashi K, Miller RG, Brownell AK. Central core disease: ultrastructure of the sarcoplasmic reticulum and T tubules. Muscle Nerve. 1989; 12: 95-102.
6. Lamont PJ, Dubowitz V, Landon DN, Davis M, Morgan-Hughes JA. Fifty-year follow-up of a patient with central core disease shows slow but definite progression. Neuromuscul Disord. 1998; 8: 385-391.
7. MacLennan DH. Discordance between phenotype and genotype in malignant hyperthermia. Curr Opin Neurol. 1995; 8: 397-401.
8. Magee KR, Shy GM. A new congenital non-progressive myopathy. Brain. 1956; 79: 610-621.
9. Manzur AY, Sewry CA, Ziprin J, Dubowitz V, Muntoni F. A severe clinical and pathological variant of central core disease with possible autosomal recessive inheritance. Neuromuscul Disord. 1998; 8: 467-473.
10. Mrozek K, Strugalska M, Fidzianska A. A sporadic case of central core disease. J Neurol Sci. 1970; 10: 339-348.
11. Neville HE, Brooke MH. Central core fibers: structured and unstructured. In: Kakulas BA(ed). Basic research in myology. Amsterdam: Excerpta Medica; 1973. p. 497-511.
12. Palmucci L, Schiffer D, Monga G, Mollo F, Marchi M. Central core disease: histochemical and ultrastructural study of muscle biopsies of father and daughter. J Neurol. 1978; 218: 55-62.
13. Patterson VH, Hill TR, Fletcher PJ, Heron JR. Central core disease: clinical and pathological evidence of progression within a family. Brain. 1979; 102: 581-594.
14. Tilgen N, Zorzato F, Halliger-Keller B et al. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet. 2001; 10: 2879-2887.
15. Vita G, Migliorato A, Baradello A et al. Expression of cytoskeleton proteins in central core disease. J Neurol Sci. 1994; 124: 71-76.